{"id":22067,"date":"2026-06-17T01:23:00","date_gmt":"2026-06-16T23:23:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=bdc46d98462607833fa94ab465ca165e"},"modified":"2026-06-17T01:23:00","modified_gmt":"2026-06-16T23:23:00","slug":"medpace-holdings-inc-to-report-second-quarter-2026-financial-results-on-july-22-2026","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=22067","title":{"rendered":"Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026"},"content":{"rendered":"<p>CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (\u201cMedpace\u201d) today announced that it will report its second quarter 2026 financial results after the market close on Wednesday, July 22, 2026. The Company will host a conference call the following morning, Thursday, July 23, 2026, at 9:00 a.m. ET to discuss these results.<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260616064111\/en\/729763\/5\/Medpace_logo_tagline.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260616064111\/en\/729763\/22\/Medpace_logo_tagline.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260616064111\/en\/729763\/5\/Medpace_logo_tagline.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260616064111\/en\/729763\/21\/Medpace_logo_tagline.jpg\" \/><\/a><p>\nTo participate in the conference call, interested parties must register in advance by clicking on <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2F7e6OCyPvKPtryyYPyURsvUxjwYY%3Fdomain%3Dregister-conf.media-server.com&amp;esheet=54555537&amp;newsitemid=20260616064111&amp;lan=en-US&amp;anchor=this+link&amp;index=1&amp;md5=72d986a6fe2b2a751ee4795220626e77\" rel=\"nofollow\" shape=\"rect\">this link<\/a>. While it is not required, it is recommended you join 10 minutes prior to the event start. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique PIN that can be used to access the call.<\/p><p>\nTo access the conference call via webcast, visit the \u201cInvestors\u201d section of Medpace\u2019s website at <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Finvestor.medpace.com%2F&amp;esheet=54555537&amp;newsitemid=20260616064111&amp;lan=en-US&amp;anchor=investor.medpace.com&amp;index=2&amp;md5=24032c467a7078dce5a21b7bf567e4b7\" rel=\"nofollow\" shape=\"rect\">investor.medpace.com<\/a>. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.<\/p><p>\nA supplemental slide presentation will also be available at the \u201cInvestors\u201d section of Medpace\u2019s website prior to the start of the call.<\/p><p>\n<b>About Medpace<\/b><\/p><p>\nMedpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace\u2019s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 6,300 people across 46 countries as of March 31, 2026.<\/p><br\/> <b>Contacts<\/b> <br\/><p>\nInvestor Contact:\n<br\/>David Ruhe\n<br\/>283-227-6472\n<br\/><span class=\"bwuline\"><a  href=\"mailto:d.ruhe@medpace.com\" rel=\"nofollow\" shape=\"rect\">d.ruhe@medpace.com<\/a><\/span><\/p><p>\nMedia Contact:\n<br\/>Michael Maley\n<br\/>283-227-6367\n<br\/><a  href=\"mailto:m.maley@medpace.com\" rel=\"nofollow\" shape=\"rect\">m.maley@medpace.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>CINCINNATI&#8211;(BUSINESS WIRE)&#8211;Medpace Holdings, Inc. (Nasdaq: MEDP) (\u201cMedpace\u201d) today announced that it will report its second quarter 2026 financial results after the market close on Wednesday, July 22, 2026. The Company will host a conference call the&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-22067","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/22067","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22067"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/22067\/revisions"}],"predecessor-version":[{"id":22068,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/22067\/revisions\/22068"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22067"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22067"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22067"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}